---
title: "Avanos Medical, Inc. (NYSE: AVNS) to discuss Q4 and full year 2025 financial results on Feb. 24 at 9 a.m. ET through webcast."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276081043.md"
description: "Avanos Medical, Inc. (NYSE: AVNS) based in Alpharetta, Georgia, is set to host a conference call on Feb. 24, 2026, at 9 a.m. Eastern Time to discuss the financial results and key business highlights for the fourth quarter and full year of 2025. This webcast will be available to the public. The company will also release a detailed news statement providing further information."
datetime: "2026-02-16T22:25:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276081043.md)
  - [en](https://longbridge.com/en/news/276081043.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276081043.md)
---

# Avanos Medical, Inc. (NYSE: AVNS) to discuss Q4 and full year 2025 financial results on Feb. 24 at 9 a.m. ET through webcast.

Avanos Medical, Inc. (NYSE: AVNS) based in Alpharetta, Georgia, is set to host a conference call on Feb. 24, 2026, at 9 a.m. Eastern Time to discuss the financial results and key business highlights for the fourth quarter and full year of 2025. This webcast will be available to the public. The company will also release a detailed news statement providing further information.

### Related Stocks

- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [000933.CN](https://longbridge.com/en/quote/000933.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [FDA approves FoundationOne CDx as TEPMETKO companion diagnostic in NSCLC](https://longbridge.com/en/news/287246470.md)
- [Ontada Integrates Florida Cancer Specialists & Research Institute Data to Enrich Its Data Ecosystem](https://longbridge.com/en/news/287218916.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)